Literature DB >> 28877054

Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.

Tatjana Antic1, Jerome B Taxy, Mir Alikhan, Jeremy Segal.   

Abstract

A 36-year-old male was found to have a 7.0 cm left upper pole renal mass on renal ultrasound. Following nephrectomy, the mass was grossly ill-demarcated, friable and red-brown, invading renal parenchyma, hilar fat and the renal vein. Microscopically, the tumor had a nested and papillary architecture. The cells demonstrated abundant clear and eosinophilic cytoplasm and focal intracytoplasmic melanin pigment. Nucleoli were prominent. By immunohistochemistry, the tumor was positive for TFE3; HMB-45 stained approximately 5% of tumor cells corresponding to the histologic melanin pigment, which was confirmed with Fontana-Masson stain with bleach. Immunostains for PAX8, CD10, MiTF, and CAIX were negative; keratins Cam 5.2 and AE1/AE3 were focally positive. Targeted next-generation sequencing revealed an ARID1B-TFE3 gene fusion. Melanotic Xp11 renal cell carcinoma is a rare, pigment containing translocation variant demonstrating overlapping features with melanoma and is usually associated with an SFPQ-TFE3 gene fusion. The patient is alive and without evidence of disease 7 years after his diagnosis. The combination of high grade histopathology, the presence of melanin, absent PAX8, keratin positivity, and relatively indolent clinical behavior with a unique translocation may warrant recognition as a distinct renal cell carcinoma translocation subtype.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28877054     DOI: 10.1097/PAS.0000000000000927

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  MiT family translocation renal cell carcinomas: A 15th anniversary update.

Authors:  Jatin S Gandhi; Faizan Malik; Mahul B Amin; Pedram Argani; Armita Bahrami
Journal:  Histol Histopathol       Date:  2019-09-06       Impact factor: 2.303

2.  A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor.

Authors:  Pedram Argani; Lei Zhang; Yun-Shao Sung; Marissa J White; Karin Miller; Mark Hopkins; Donald Small; Christine A Pratilas; David Swanson; Brendan Dickson; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-08-13       Impact factor: 5.006

3.  Genetic diversity in alveolar soft part sarcoma: A subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors.

Authors:  Brendan C Dickson; Catherine T-S Chung; David J Hurlbut; Paula Marrano; Mary Shago; Yun-Shao Sung; David Swanson; Lei Zhang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-08-21       Impact factor: 5.006

Review 4.  A review of neoplasms with MITF/MiT family translocations.

Authors:  Shuanzeng Wei; Joseph R Testa; Pedram Argani
Journal:  Histol Histopathol       Date:  2022-02-02       Impact factor: 2.303

Review 5.  Microphthalmia family of transcription factors associated renal cell carcinoma.

Authors:  Ling Xie; Yifen Zhang; Chin-Lee Wu
Journal:  Asian J Urol       Date:  2019-05-03

6.  EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.

Authors:  Antic Tatjana; Melissa Y Tjota; Peter H O'Donnell; Scott E Eggener; Piyush K Agarwal; Rishikesh Haridas; Jeremy Segal; Peng Wang
Journal:  Virchows Arch       Date:  2021-06-14       Impact factor: 4.064

7.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

Review 8.  Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature.

Authors:  Hongbiao Jing; Hong Wei; Hongtu Yuan; Yahong Li; Ning Li; Dianbin Mu
Journal:  Diagn Pathol       Date:  2018-08-13       Impact factor: 2.644

9.  A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion.

Authors:  Hong Ye; Shuming Qin; Ning Li; Min Lin; Yanmei Xu; Xiaomei Li
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 10.  Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.

Authors:  Yuxiong Wang; Yuantao Wang; Mingliang Feng; Xin Lian; Yongsheng Lei; Honglan Zhou
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.